Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Gallego

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
JAMA Neurology|June 20, 2023
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical TrialMacarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Nature Communications|May 30, 2019
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse modelsNaiara Martínez-Vélez, Marc Garcia-Moure, Miguel Marigil, et al.
Neuro-Oncology|March 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma modelsDaniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
JAMA Neurology|June 20, 2023
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical TrialMacarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Nature Communications|May 30, 2019
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse modelsNaiara Martínez-Vélez, Marc Garcia-Moure, Miguel Marigil, et al.
Neuro-Oncology|March 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma modelsDaniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, et al.
Pageof 5